Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The new gel for psoriasis is effective, stable, and easy to apply.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Upadacitinib may effectively treat resistant lichen planopilaris.

Kūlaris improved quality of life for acne sufferers without side effects.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

Psoriasis and gout are linked, with each increasing the risk of the other.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.